#acellular biologic therapeutic

[healthcarehubhh]

The Global Amniotic Membrane Market will grow at highest pace owing to rising aging population.

Amniotic Membrane or amnion refers to the innermost layer of the placenta. It acts as a physical barrier between the fetus and the mother's uterus. Amniotic membrane finds wide application in wound healing and surgical reconstruction owing to its anti-inflammatory, anti-scarring, and anti-angiogenic properties. It is used in treatments involving burns, skin injuries, ophthalmic defects, and chronic non-healing ulcers. The growing geriatric population suffering from chronic diseases and wounds has increased the demand for amniotic membrane products in wound management. The Global Amniotic Membrane Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the Amniotic Membrane market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. The growing aging population and increase in chronic wounds has augmented the demand for amniotic membrane products. Technological advancements such as development of micronized and acellular amniotic membranes formulations have expanded the application scope of amniotic membranes. Market Trends Cryopreservation of Amniotic Membranes - Cryopreservation allows for long-term storage of amniotic membranes at sub-zero temperatures while maintaining viability and key properties. This enables stockpiling and just-in-time delivery of amniotic membranes to clinics and hospitals. Micronization of Amniotic Membranes - Micronization is the process of comminuting amniotic membranes into micron-sized powder. This improves handling, storage, and delivers concentrated growth factors effectively to target sites. Micronized amniotic membranes have applications in wound healing and regenerative medicine. Market Opportunities Rising Aging Population - The growing geriatric population prone to chronic wounds, burns, and non-healing injuries will drive the demand for amniotic membrane products in wound management over the forecast period. Expanding Applications in Regenerative Medicine - Increased research on regenerative potential of amniotic membranes is extending their use in treatment of degenerative ocular surface diseases, lower urinary tract conditions, musculoskeletal disorders thereby opening new opportunities. Impact of COVID-19 on Amniotic Membrane Market: The COVID-19 pandemic posed significant challenges to the amniotic membrane market. During the early phases of the pandemic, restrictions on non-essential medical procedures led to supply chain disruptions and uncertainties around product availability. Manufacturers faced challenges in sourcing raw materials and maintaining continuous production due to lockdowns and social distancing measures. Movement restrictions also impacted the delivery of products to customers. The focus of healthcare resources on critical COVID-19 patients resulted in delays and postponements of other medical procedures that utilize amniotic membrane products. This adversely affected market demand in the short term.

[cricsart]

More acellular items are accessible on the lookout, including NEOX/CLARIX from Amniox Clinical , EpiFix from MiMedx Gathering , and Biovance from Alliqua Biomedical. These acellular items don't contain dynamic or living cells, however may contain and animate development variables, cytokines, and framework proteins, giving mechanical substrate to tissue development. Contrasted and cell items, they have less administrative and logical difficulties.

[focusonthegoodnews]

100 percent recovery rate for COVID-19 patients treated with Zofin™

100 percent recovery rate for COVID-19 patients treated with Zofin™

Good News Notes: “Organicell Regenerative Medicine  has announced that all ten hospitalised COVID-19 patients treated with Zofin™ have recovered and been discharged from hospital. These patients are the first to be treated with the acellular biologic therapeutic derived from perinatal sources in a Phase I/II randomised, double-blinded, placebo-controlled trial. The study is evaluating the safety…

[vynzresearchindia]

Global Wound Care Biologics Market Size, Share, and Demand Analysis Report, 2027

The Global Wound Care Biologics Market size was valued at USD 1,848.7 million by 2020 and is expected to develop at a CAGR of 5.7% during the forecast period (2021-2027), according to VynZ Research. For the forecast year 2021-2027, as well as the historical period 2015-2019, the Global Wound Care Biologics Market has been studied.

The research report provides a comprehensive and insightful examination of the Global Wound Care Biologics Market and includes market analysis on segmentation, dynamics, competition, and regional development. It considers the Global Wound Care Biologics Market’s CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, pricing, and other significant parameters. The forecasts in the report are based on well-established research methodology and assumptions.

Get the sample copy of the Market Research @ https://www.vynzresearch.com/healthcare/wound-care-biologics-market/request-sample

Individual strategies were examined in the Global Wound Care Biologics Market study, followed by business profiles of Global Wound Care Biologics Market providers. The study includes an 'Industry Landscape' section that provides readers with a comprehensive view and firms’ market share analysis of major industry players in the Global Industry.

Most of the major players in the Global Wound Care Biologics Market are profiled in the report. The strengths and weaknesses, business developments, recent innovations, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of key market competitors are all covered in the company profiling section.

The following are some of the major and developing players in the Global Market:

Integra LifeSciences Corporation

MiMedx Group Inc.

Wright Medical Group N.V.

Osiris Therapeutics Inc.

Vericel Corporation

Kerecis Limited

Anika Therapeutics Inc.

Acell Inc.

Skye Biologics Inc.

Solsys Medical

Marine Polymer Technologies Inc.

Kerecis Limited

Smith & Nephew plc

Mölnlycke Health Care AB.

Breakdown of The Segments:

The Global Wound Care Biologics Market is segmented by Product, Durability, Application, End-User and Geography in this study. This segmentation aids executives in planning their products and budgets depending on each segment's expected growth rates.

By Product

Growth Factors

Skin Substitutes

Cell-Based

Collagen-Based

Enzyme-Based

Others

Platelet-Derived Growth Factors (PDGF)

Epidermal Growth Factors (EGF)

Insulin-Like Growth Factors (IGF)

Transforming Growth Factor-Beta (TGF-β)

Fibroblast Growth Factors (FGF)

Others

Acellular Animal-Derived

Human Donor-Tissue Derived

Biosynthetic

Viable

Non-viable

By Durability

Permanent

Temporary

By Application

Chronic

Acute

By End-User

Hospitals and Specialty Wound Care Clinics

Home Healthcare

Others

Geographical Viewpoint:

The research overview provides the major industry trend and the global market's predicted volume based on the regional analysis. The elements that have driven and hampered the market's expansion are also mentioned in this market research analysis. The study is also equipped with the most advanced and effective techniques for gathering, recording, estimating, and evaluating market data.

FAQ

Who are the most dominant players in the global market, and what elements are assisting them in gaining a competitive advantage?

What are the strategies adopted by the key industry players to gain traction in the industry?

By the end of the forecast period, what will the market size and growth rate?

What are the biggest Global Market trends that are influencing market growth?

In the global market, which segment had the biggest revenue share?

Explore More Reports by VynZ Research:

Global Floating Farms Market – Analysis and Forecast (2022-2030)

Global Residential Energy Storage Market - Analysis and Forecast (2022-2030)

Global Photovoltaic Market – Analysis and Forecast (2022-2030)

About VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

[newinnovationalmarketresearch]

Home Textiles Market 2025 Report by Growth, Trends, Industry Outlook, Growth Opportunity

With reference to the report published by the experts the scope of the global Home Textiles Market was appreciated at US$ 94.73 billion in 2018. It is estimated to touch US$ 133.4 billion during the forecast period with a CAGR of 5.01% during the period of 2019 to 2025.

 Drivers:

 Development in end-use segments, for example residential and hospitality, together with the increasing attentiveness regarding altering inclinations of home-based interior decoration is expected to motivate the global home textiles industry. Increasing sector of real estate and refining criterions of living style have caused in an augmented expenditure on homebased beautification and interior. Similarly, this expected to be one of the important features boosting the development during the years of forecast. Furthermore, altering inclinations in home-based furnishing is estimated to additionally increase the development for home textiles.

 Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/home-textiles-market/request-sample

 Market Synopsis of Home Textiles Market:

 Additionally, Home Textiles is also inclusive of tissue engineering. Bioengineers along with biologists, nanotechnologists, physicians and other specialties are working upon connecting tissues and potential organs or scaffolds made of biological materials to resemble cartilage, bone and other structure that supports tissue and organ growth.

 On a commercial scale, many scientists are utilizing Home Textiles approaches to rebuild stem cells and tissues and in some clinical trials, practicing novel therapies is a gateway to modern way of treating degenerative diseases. Hence, Home Textiles as a part of intrinsic therapy is gaining traction presently and the Home Textiles market is anticipated to grow at a higher CAGR during the forecast period.

  The key driving factors responsible for the growth of Home Textiles market includes government and private subsidy to assist development of Home Textiles. Additionally, rising incidences of chronic diseases and genetic ailments, rise in healthcare expenditure and massive growth in geriatric population is anticipated to fuel the market growth for forecast period. However, market entrants and product failures are likely to impede market growth during the forecast period.

 Home Textiles market is segmented into cell-based products and acellular products, based on type. Home Textiles market is segmented into cell therapy, gene therapy, tissue engineering and immunotherapy, based on therapy. Home Textiles market is segmented into orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system disease, ocular, autoimmune, rare diseases and dental/oral diseases.

 Home Textiles market spans North America, Latin America, Europe, Asia-Pacific, Middle-East & Africa. North America is anticipated to grow at a higher CAGR during the forecast period. APAC regions are anticipated to rise at a higher CAGR owing to rise in research activities in Asian countries, availability of funding for research and establishment of research centers responsible for the APAC market growth. The key players in the Home Textiles market include Organogenesis Inc, Osiris Therapeutics Inc, Vericel Corporation Inc, Stryker Corporation, NuVasive Inc, Medtronic, Acelity, Integra LifeSciences, Cook Biotech Inc and C.R. Bard.

 View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/home-textiles-market

 Table of Contents:-

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Home Textiles: Market Variables, Trends & Scope              

Chapter 4 Home Textiles: Product Estimates & Trend Analysis

Chapter 5 Home Textiles: Application Estimates & Trend Analysis

Chapter 6 Home Textiles: End-use Estimates & Trend Analysis

Chapter 7 Home Textiles: Industrial End-use Estimates & Trend Analysis

Chapter 8 Home Textiles: Regional Estimates & Trend Analysis

Chapter 9 Competitive Landscape

Chapter 10 Home Textiles: Manufacturers Company Profiles

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

[marketresearchreportinsight]

Regenerative Medicine Market 2025 - Industry Size, Trends, Demand, Growth, Share, Opportunities and Analysis

28 January 2019 -  Global Regenerative Medicine Market is witnessing a transitional phase in the recent years and continues to evolve rapidly in the assessment period. Regenerative medicine is a novel scientific approach emphasizing on harnessing the power of stem cells and body’s own regenerative competences to regain function to damaged cells, organs and tissues. Intensive research is conducted to grasp why and how several types of cells have ability to mature into specialized tissues and cells.

Additionally, regenerative medicine is also inclusive of tissue engineering. Bioengineers along with biologists, nanotechnologists, physicians and other specialties are working upon connecting tissues and potential organs or scaffolds made of biological materials to resemble cartilage, bone and other structure that supports tissue and organ growth.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/regenerative-medicine-market

Regenerative medicine also helps in understanding and promoting the ability of an organ or tissue to repair by self. Several adult tissues contain stem cells, but stem cell are dysfunctional or impaired by disease. By using certain factors to trigger and promote essential processes in a diseased organ to unlock many novel therapies towards degenerative diseases.

On a commercial scale, many scientists are utilizing regenerative medicine approaches to rebuild stem cells and tissues and in some clinical trials, practicing novel therapies is a gateway to modern way of treating degenerative diseases. Hence, regenerative medicine as a part of intrinsic therapy is gaining traction presently and the regenerative medicine market is anticipated to grow at a higher CAGR during the forecast period.

The key driving factors responsible for the growth of regenerative medicine market includes government and private subsidy to assist development of regenerative medicine. Additionally, rising incidences of chronic diseases and genetic ailments, rise in healthcare expenditure and massive growth in geriatric population is anticipated to fuel the market growth for forecast period. However, market entrants and product failures are likely to impede market growth during the forecast period.

Regenerative medicine market is segmented into cell-based products and acellular products, based on type. Regenerative medicine market is segmented into cell therapy, gene therapy, tissue engineering and immunotherapy, based on therapy. Regenerative medicine market is segmented into orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system disease, ocular, autoimmune, rare diseases and dental/oral diseases.

Regenerative medicine market spans North America, Latin America, Europe, Asia-Pacific, Middle-East & Africa. North America is anticipated to grow at a higher CAGR during the forecast period. APAC regions are anticipated to rise at a higher CAGR owing to rise in research activities in Asian countries, availability of funding for research and establishment of research centers responsible for the APAC market growth. The key players in the regenerative medicine market include Organogenesis Inc, Osiris Therapeutics Inc, Vericel Corporation Inc, Stryker Corporation, NuVasive Inc, Medtronic, Acelity, Integra LifeSciences, Cook Biotech Inc and C.R. Bard.

Market Segment:

This report focuses on the global top players, covered

• Acelity

• DePuy Synthes

• Medtronic

• ZimmerBiomet

• Stryker

• MiMedx Group

• Organogenesis

• UniQure

• Cellular Dynamics International

• Osiris Therapeutics

• Vcanbio

• Gamida Cell

• Golden Meditech

Market segment by Regions/Countries, this report covers

• United States

• Europe

• China

• Japan

• Southeast Asia

• India

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/regenerative-medicine-market/request-sample

[coolluminaryland-blog1]

Breast Reconstruction Market to Reach US$ 1,358.7 Mn by 2026

Transparency Market Research (TMR) has published a new report titled, “Breast Reconstruction Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global breast reconstruction market was valued at US$ 893.7 Mn in 2017 and is projected to expand at a CAGR of 4.8% from 2018 to 2026. Rise in prevalence breast cancer, launch of new products by companies, and use of silicone breast implants and acellular dermal matrix for breast reconstruction are anticipated to augment the global market from 2018 to 2026.

Rise in Prevalence of Breast Cancer to Propel Market

Prevalence of breast cancer among women is increasing. After skin cancer, breast cancer has the highest prevalence among women across the globe. According to the World Cancer Research Fund International, nearly 2 million new cases of breast cancer were reported globally in 2018. Belgium, Luxembourg, and the Netherlands are the top three countries in Europe with the highest rate of breast cancer. According to data provided by the Continuous Update Project Panel of World Cancer Research Fund International, consumption of alcoholic drinks is one of the primary causes of premenopausal breast cancer.

Request a PDF Sample –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=57762

Launch of New Products by Players to Augment Market

Leading players in the global breast reconstruction market have launched new products such as silicone-filled breast implants, acellular dermal matrix, and tissue expanders. Usage of acellular dermal matrices in breast reconstruction has increased due to rise in awareness about single-stage breast reconstruction. For instance, in September 2018, Mentor Worldwide LLC launched CPX4 Smooth Breast Tissue Expander in the U.S., thereby expanding the line of CPX4 Breast tissue expanders that can be used in prepectoral and submuscular breast reconstruction.

Products Recalls by Regulatory Authorities to Restrain Market

Product recalls by regulatory authorities such as the Food and Drug Administration (FDA) and the National Agency for Medicines and Health Products Safety (ANSM) affect the revenue and market share of companies. In February 2014, ANSM recalled Cereform silicone gel-filled breast implants, as the sterilization process for the manufacture of the implant was not as per the set international standards. Additionally, in November 2014, the Therapeutic Goods Administration (TGA) suspended the sales of Cereform. Hence, product recalls are expected to restrain the market during the forecast period.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57762

Asia Pacific Market to Witness Strong Growth

In terms of revenue, the breast reconstruction market in Asia Pacific is projected to expand at a high CAGR during the forecast period. Factors driving the market in the region are increase in awareness about breast reconstruction after mastectomy and use of acellular dermal matrix to support breast implant. Furthermore, geographical expansion & launch of new products by market players, product approvals in Japan and China, and increase in the number of women opting for breast reconstruction propels the market in the region. According to the American Society of Plastic Surgeons, in 2017, Japan reported the largest number of breast procedures in Asia Pacific, accounting for 0.3% of the breast procedures performed globally. Moreover, rise in focus on women’s health and availability of technologically advanced medical devices for diagnostic and therapeutic purposes in countries such as China, India, and Australia are expected to boost demand for breast implants. This in turn is likely to augment the market in Asia Pacific during the forecast period.

Competitive Landscape in Breast Reconstruction Market

The report also provides profiles of leading players operating in the global breast reconstruction market. These include Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. Increase in sales of breast implants is an important factor for the key players in the market to generate high revenue. Development of customized breast implants and increase in research & development activities in biologics for breast reconstruction are anticipated to create significant opportunities in the market.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

[data-bridge-market-research]

The Global Regenerative Medicine Market is expected to reach USD 57730.89 million by 2025, from USD 7077.2 million in 2017 growing at a CAGR of 30.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Definition: Global Regenerative Medicine Market

Regenerative medicine presents with opportunities to change the treatment options and offers complete cure for the diseases. Regenerative medicines are useful for various purposes like replace, repair, regenerate tissues and organs gets affected due to disease, natural aging process or injury. There are number of companies that are indulging in the research and development of such therapies now. For instance, according to published article, in 2014, regenerative medicine reports 4749 registries of clinical trials related to stem cell treatment. In recognition of the integral role of the Food and Drug Administration (FDA) in the successful development of this field, NIH is leading the RMIP in coordination with FDA. According to the Centers for Disease Control and Prevention (CDC), over 117 million individuals in the US were suffering from one or more than that chronic health conditions in 2012. In 2016, it was found that there was an increase in the prevalence of acute wounds such as surgical and traumatic wounds across the globe and also observed that surgical wounds in global prevalence was 135,000.

Major Market Drivers and Restraints:

Increase in prevalence of chronic diseases.

emergence of stem cell technology

for research on untapped potential of nanotechnology

rise in incidence of degenerative diseases

High cost for advancement in the technology.

Lack of operational efficiency.

Market Segmentation: Global Regenerative Medicine Market

The global regenerative medicine market is segmented based on product type, therapy, material, application and geographical segments.

Based on product type, the market is segmented into cell based and acellular.

On the basis of therapy, the market is segmented tissue engineering, immunotherapy, cell therapy and gene therapy.

On the basis of material, the market is segmented into synthetic material, pharmaceutical,, genetically engineered material and  biologically derived material.

On the basis of application, the market is segmented into dermatology, orthopedic & musculoskeletal disorders and cardiology oncology

Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Key Developments in the Market:

In December 2016, the Regenerative Medicine Innovation Project (RMIP) established to accelerate the field by supporting clinical research on adult stem cells along with promoting the highest standards for carrying out scientific research and protecting patient safety.

In April 2018, The Food and Drug Administration (FDA) have programs considered to expedite the drug development and review processes for promising pipeline products. These programs include accelerated approval, fast track, breakthrough and priority review designations. The newest of these programs is Regenerative Medicine Advanced Therapy (RMAT).

Competitive Analysis: Global Regenerative Medicine Market

The global regenerative medicine market is highly fragmented and the major players have used various strategies such as number of therapies, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of regenerative medicine market  for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors/Players: Global Regenerative Medicine Market

Some of the major players operating in the global regenerative medicine market are Integra LifeSciences Corporation, MiMedx Group, Inc, AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Baxter and Nuvasive, Inc, Organogenesis Inc., Osiris Therapeutics, Inc. (U.S.), Vericel Corporation, Stryker Corporation, and NuVasive, Inc., Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Cook Biotech Inc.,  C.R. Bard (U.S.), Vericel Corporation, U.S. Stem Cell, Athersys, Inc., CryoLife, Inc., Medtronic Plc., among others.

Research Methodology: Global Regenerative Medicine Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Reasons to Purchase this Report

Current and future of Global Regenerative Medicine Market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report

All segmentation provided above in this report is represented at country level.

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

[merryjain12-blog]

Global Wound Care Biologics Market: Key Vendors, Quality, Reliability & Innovation In Technology

Global Wound Care Biologics Market Research report covers Definition, major Drivers, Restraint, Segmentation, Market Analysis, Major Key players which dominate the market. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.  

The Global Wound Care Biologics Market is expected to reach USD 2.78 billion by 2025, from USD 1.29 billion in 2017 growing at a CAGR of 10.09% during the forecast period of 2018 to 2025. 

To Get A Free Sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-wound-care-biologics-market

This Report Consist of :

·         No of pages : 350

·         No of Figures: 60

·         No of Tables: 220

Global Wound Care Biologics Market, By Product (Biologic Skin Substitutes {Human Donor Tissue-derived Products, Biosynthetic Products} Topical Agents), By Wound Type (Ulcers { Venous Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Other Ulcers} Surgical and Traumatic Wounds, Burns), By End Users (Hospitals, ASCs, Burn Centers and Wound Clinics), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025.

Definition:

The other name of Biologics is biopharmaceuticals which are extracted from biological sources. They are found in the form of medical, biological, any pharmaceutical drug product. Hence the use of biologicals has increased significantly in past years; these are used in treating the wounds primarily. Several devices are currently enhancing the natural repair mechanisms; however the quest for tissue regeneration is becoming clearer. As a matter of fact there is no single biologic that can provide all the needed components for dermal regeneration. These treatments related to the wound care biologics help in the refurbishment of the inborn repair mechanisms and may involve the application of active biological agents, for example plant-derived active biomolecules which exhibit antioxidant, antimicrobial, or anti-inflammatory attributes. Substances that are prepared via a living are used in the prevention, diagnosis, or treatment of cancer and other diseases are called as biologics. Biological drugs include antibodies, interleukins, and vaccines.

There are skin substitutes in wound care biologics which can be classified as temporary or permanent and synthetic or biological some of them are temporary skin substitutes, permanent skin substitutes, biological skin substitutes, xenograft, skin allograft, amnion, cultured epithelial auto grafts and synthetic skin substitutes. Biosynthesis is also called anabolism, there are biosynthetic products.

Major Market Drivers and Restraints:

·         Rising incidences of burn injuries

·         Rapid growth in the geriatric population

·         Growing incidence of ulcers and target conditions

·         Innovation in wound care biologics

·         Awareness programs for wound care treatment and management

·         High cost of wound treatment and wound care biologics

·         Risk of skin substitute failure.

Have Query? Speak to Our Expert @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-wound-care-biologics-market

Segmentation:

The global wound care biologics market is segmented based on

·         product type

·         end user

·         application

·         distribution channel

·         geographical segments

Based on product, the global wound care biologics market is segmented into biologic skin substitutes and topical agents. The sutures market segment is further segmented into human donor tissue-derived products, acellular animal-derived products and biosynthetic products.

Based on wound type, the global wound care biologics market is classified into ulcers, surgical and traumatic wounds, and burns. The ulcers market is further sub-segmented into venous ulcers, diabetic foot ulcers, pressure ulcers and other ulcers.

Based on end users the market is segmented into Hospitals, ASCs, Burn Centers and Wound Clinics.

Based on geography the global wound care biologics market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Competitive Analysis:

The global wound care biologics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of wound care biologics market for global, Europe, North America, Asia Pacific and South America.

To View TOC in Detail @ https://databridgemarketresearch.com/toc/?dbmr=global-wound-care-biologics-market

Key Players:

Some of the major players operating in the global wound care biologics market are

·         Smith & Nephew

·         Mölnlycke Health Care AB (Investor AB)

·         Integra Lifesciences

·         Wright Medical

·         Mimedx Group

·         Vericel

·         Anika Therapeutics

·         Osiris Therapeutics

·         Organogenesis

·         Kerecis

·         Solsys Medical and Acell

·         Marine Polymer Technologies

Research Methodology:

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Responds To Purchase this Report:

·         Current and future of global wound care biologics market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

·         Regions/countries that are expected to witness the fastest growth rates during the forecast period

·         The latest developments, market shares, and strategies that are employed by the major market players

Customization of This Report:

·         The report includes the complete segmentation displayed above across all above mentioned countries

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).

To View Full Report @ https://databridgemarketresearch.com/reports/global-wound-care-biologics-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

 Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

[foodandbeverages]

Regenerative Medicine Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital disorders. According to findings of various studies, regenerative medicines can also be useful in treating both chronic and acute disorders in terms various context of abnormalities such as cardiovascular diseases, dermal wounds, and in treatment of certain types of cancer. Furthermore, the current therapy of organ and tissue transplantation for treating organ and tissue failures can result in patient death due to limited or no donor supply and often result in severe complications in immune system. Regenerative medicine helps alleviate such issues to a major extent.

Request Sample of Regenerative Medicine Market : https://www.coherentmarketinsights.com/insight/request-sample/163

Furthermore, players in the regenerative medicine market focus on fueling growth in the pharmaceutical sector by adopting various strategies such as including the use of different materials in the preparation that can offer better results and newly generated cells or with the combination of both, in turn replacing the missing tissue and effectively serving its functions. The innate healing response of the human body can also be favored to support the regenerating activities. Age is a major factor that can affect the regeneration of the desired part, as the body’s ability to regenerate is low among adults as compared to young population or lower vertebrates. Materials play an important role in regeneration activities, as they form the basis of the growth and replacement, as they can mimic the native extracellular matrix (ECM) of tissues.

Regenerative medicine market taxonomy:

By Technology

Biomaterial

Tissue Engineering

Stem Cell Therapy

By Product Type

Cell-based products

Acellular products

By Application

Orthopedic & Musculoskeletal Disorders

Cardiology

Dermatology

Diabetes

Central Nervous System Disorders

Others

By Material

Algae Derived Alginate

Synthetic Polymer

Poly-lactide-coglycolide

poly-ethylene glycol

Hydrogels

By Agent Type

Biologics

Autologous fibroblasts

Hematopoietic stem and progenitor cells

Cell-based medical devices

Allogenic fibroblasts

Cell extraction

Biopharmaceuticals

Tri-calcium Phosphate

Osteogenic Protein

Rising number of bone and joint surgeries to fuel the growth of regenerative medicine market in the near future:

Rise in number of trauma case globally is expected to favor growth of the regenerative medicine market in the near future. There are different types of prosthetics and implants that are used to support the human body movement in case of trauma and severe injury. However, a majority of the young population perceives these to be an eye sore and are increasingly inclined towards non-obtrusive options that do not drastically alter their physical appearance and activities. Regenerative medicine provides a viable alternative to such conventional methods and also reduces risk of deformity. However, regenerative medicine is significantly expensive as compared to conventional methods of treatment. Also, this treatment option is barely effective for treatment of the geriatric population. These factors impede growth of the market to a certain extent. According to University of California, Los Angeles (UCLA) Department of Orthopedic Surgery, in 2015, around 7,515 orthopedic surgeries were conducted in the U.S. by the department from July 2014 to June 2015. This number is expected to rise due to rise in number of orthopedic trauma cases in the region, which is further projected to favor growth of the regenerative medicine market in the near future.

Developed regions major growth engines of the regenerative medicine market

Developed countries such as the U.S., Germany, U.K., France, and Japan have a highly developed market for regenerative medicine, mainly due to technical advancements in the region. According to Regenerative Medicine Annual Report, in 2013, in regenerative medicine market there has been various product approvals along with annual revenue of around US$ 1 billion. Thus, this sector is expected to attract attention from investors and industry partners in the near future. Furthermore, as per the report, around 60,000 stem cell transplants are performed globally each year to treat various cancers and blood-based disorders. This augments growth of the market of regenerative medicine. Also, as observed by Alliance for Regenerative Medicine (ARM), in 2012, the bio-therapeutic companies distributing cell therapy products generated around US$ 900 million, with 160,000 patients undergoing various related treatments.

Request the table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/163

Major acquisitions to support growth of regenerative medicine market

There are few recent acquisitions by the big brands in biotechnology that is expected to favor growth of regenerative medicine industry. In August 2016, Medtronic Inc. acquired Heart Ware International, Inc. — a provider of technologies for less-invasive, miniaturized, mechanical circulatory support (MCS) for treatment of patients with advanced heart failure. This acquisition is further expected to favor the working efficiency of the company and broadens its product portfolio. Key players operating in the regenerative medicine market include Depuy Synthes, Inc., Orthofix, Inc., NuVasive, Inc. and Zimmer Holdings, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights 1001 4th Ave,  

#3200

Seattle, WA 98154

Tel:  +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Visit Blog : http://globalresearchtrends.blogspot.in

[healthy-insights]

Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Proteins are essential for good health; people affected by genetic disorders cannot produce these proteins. Examples of such proteins include insulin, various blood clotting factors, growth hormones and others. Protein therapy ensures efficient administration of these proteins to patients suffering from deficiency, resulting in effective therapeutic benefits. It is a type of medical treatment that possesses therapeutic effects in many diseases such as diabetes, brain diseases and cancer. Protein therapeutics are classified functionally into five major groups-

Group I: Protein therapeutics with enzymatic or regulatory activity

Group II: Protein therapeutics with special targeting activity

Group III: Protein vaccines

Group IV: Protein diagnostics

The protein therapeutics market presents immense potential due to its untapped market potential and wide range of application areas. More than 100 modified therapeutic proteins have been approved for clinical use in the U.S. and European Union. At present there are various protein therapeutics in development based on their pharmacological activity, molecular mechanism of activity and their molecular types.

Browse Full Market Research of Protein Therapeutics Market :

http://www.transparencymarketresearch.com/protein-therapeutics-market.html

The protein therapeutics market can also be segmented based on product type, indication areas and geographies. The product segment includes monoclonal antibodies (mAbs), insulin, interferon, blood clotting factors and others. The various indication areas include diabetes, cancer, neurological disorders, genetic disorders and other indications. The major factors driving the protein therapeutics market are the increasing incidence of various chronic disorders such as cardiovascular, cancer and diabetes etc. and enhanced investments for the development of novel and efficient drugs. Moreover, rising number of medical insurance services and increased outsourcing of drug development processes are also expected to boost market growth. Increased awareness and high efficiency of these therapeutics with minimal side effects results in high acceptance levels by the end users. The major challenges of this market refer to the development of efficient methodologies to study the complex biological systems, catering to the individual variations and others including resistance to therapy and ensuring target efficiency.

Patent expirations of top selling protein therapeutics may mask the growth of the market. Some of the leading manufacturers of protein therapeutics are Roche Group, Sanofi, Eli Lilly & Company, Johnson & Johnson, Novartis, Bristol Myers Squibb Co., Pfizer, Inc., Amgen, Inc., and Merck Sereno S.A.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World  

This report provides comprehensive analysis of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a technological growth map over time to understand the industry growth rate

It provides a seven-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified SWOT analysis of major market segments

Key Takeaways:

By 2023, acellular skin substitutes are expected to generate a revenue of US$2.29 bn.

Ulcers expected to be a prominent application segment by 2023, estimated to generate revenue of US$2.15 bn.

North America to continue leading demand and revenue for tissue engineered skin substitutes, expected to generate US$1.96 bn by 2023.

Key segments of the Global Tissue Engineered Skin Substitutes Market

Global Tissue Engineered Skin Substitutes Market, by Type

Acellular

Cellular Allogeneic

Cellular Autologus

Others

Global Tissue Engineered Skin Substitutes Market, by Application

Burn

Diabetic Ulcers/Vascular ulcers

Others

Global Tissue Engineered Skin Substitutes Market, by Geography

North America

Europe

Asia Pacific

Latin America

The Middle East and Africa

Get Free Sample Research Report of Protein Therapeutics Market :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2035

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com

[newinnovationalmarketresearch]

Dairy Ingredients Market 2025 Report by Emerging Trends, Application Scope, Size, Status

Dairy Ingredients Market size was estimated at 13.7 million tons in 2015 and is expected to reach USD 86.97 billion by 2024. Factors such as population starting to age, increased health issues, better awareness about the benefits of food products rich in nutrition, better production and sluggish lifestyle are expected to benefit the overall market.

 A shift in food habits, from customary food to nutritional food has been observed. The industry is extremely competitive with a huge number of companies trying to capture the market. It comprises of few leading global companies and numerous minor regional companies. The increased awareness about the health benefits of the food items rich in nutrition is expected to have positive impact on the market.

 Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/dairy-ingredients-market/request-sample

 Market Synopsis of Dairy Ingredients Market:

 Additionally, Dairy Ingredients is also inclusive of tissue engineering. Bioengineers along with biologists, nanotechnologists, physicians and other specialties are working upon connecting tissues and potential organs or scaffolds made of biological materials to resemble cartilage, bone and other structure that supports tissue and organ growth.

 On a commercial scale, many scientists are utilizing Dairy Ingredients approaches to rebuild stem cells and tissues and in some clinical trials, practicing novel therapies is a gateway to modern way of treating degenerative diseases. Hence, Dairy Ingredients as a part of intrinsic therapy is gaining traction presently and the Dairy Ingredients market is anticipated to grow at a higher CAGR during the forecast period.

  The key driving factors responsible for the growth of Dairy Ingredients market includes government and private subsidy to assist development of Dairy Ingredients. Additionally, rising incidences of chronic diseases and genetic ailments, rise in healthcare expenditure and massive growth in geriatric population is anticipated to fuel the market growth for forecast period. However, market entrants and product failures are likely to impede market growth during the forecast period.

 Dairy Ingredients market is segmented into cell-based products and acellular products, based on type. Dairy Ingredients market is segmented into cell therapy, gene therapy, tissue engineering and immunotherapy, based on therapy. Dairy Ingredients market is segmented into orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system disease, ocular, autoimmune, rare diseases and dental/oral diseases.

 Dairy Ingredients market spans North America, Latin America, Europe, Asia-Pacific, Middle-East & Africa. North America is anticipated to grow at a higher CAGR during the forecast period. APAC regions are anticipated to rise at a higher CAGR owing to rise in research activities in Asian countries, availability of funding for research and establishment of research centers responsible for the APAC market growth. The key players in the Dairy Ingredients market include Organogenesis Inc, Osiris Therapeutics Inc, Vericel Corporation Inc, Stryker Corporation, NuVasive Inc, Medtronic, Acelity, Integra LifeSciences, Cook Biotech Inc and C.R. Bard.

 View Full Table of Contents of This Report @

https://www.millioninsights.com/industry-reports/dairy-ingredients-market

 Table of Contents:-

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Dairy Ingredients: Market Variables, Trends & Scope              

Chapter 4 Dairy Ingredients: Product Estimates & Trend Analysis

Chapter 5 Dairy Ingredients: Application Estimates & Trend Analysis

Chapter 6 Dairy Ingredients: End-use Estimates & Trend Analysis

Chapter 7 Dairy Ingredients: Industrial End-use Estimates & Trend Analysis

Chapter 8 Dairy Ingredients: Regional Estimates & Trend Analysis

Chapter 9 Competitive Landscape

Chapter 10 Dairy Ingredients: Manufacturers Company Profiles

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.